Featured publications

  • Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs.

    Authors: Llaneras J, Riveiro-Barciela M, Lens S, Diago M, Cachero A, García-Samaniego J, Conde I, Arencibia A, Arenas J, Gea F, Torras X, Luis Calleja J, Antonio Carrión J, Fernández I, María Morillas R, Rosales JM, Carmona I, Fernández-Rodríguez C, Hernández-Guerra M, Llerena S, Bernal V, Turnes J, González-Santiago JM, Montoliu S, Figueruela B, Badia E, Delgado M, Fernández-Bermejo M, Iñarrairaegui M, Pascasio JM, Esteban R, Mariño Z, Buti M .
    Reference: Journal Of Hepatology 2019.
  • TIPS Indications and Contraindications—Pushing the Limits: Is Earlier Better?

    Authors: José Alberto Ferrusquía Acosta; Virginia Hernández Gea.
    Reference: Current Hepatology Reports 2019.
  • Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis.

    Authors: Enric Reverter; Juan José Lozano; Cristina Alonso; Annalisa Berzigotti; Susana Seijo; Fanny Turon; Anna Baiges; Mari Luz Martínez Chantar; José M Mato; Ibon Martínez Arranz; Vincenzo La Mura; Virginia Hernández Gea; Jaume Bosch; Juan Carlos García Pagán.
    Reference: Liver International 2019.
  • Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury

    Authors: Ruart M; Chavarria L; Campreciós G; Suárez-Herrera N; Montironi C; Guixé-Muntet S; Bosch J; Friedman S; Garcia-Pagán J; Hernández-Gea V.
    Reference: Journal Of Hepatology 2019.
  • Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis

    Authors: Reverter E, Lozano JJ, Alonso C, Berzigotti A, Seijo S, Turon F, Baiges A, Martínez-Chantar ML, Mato JM, Martínez-Arranz I, La Mura V, Hernández-Gea V, Bosch J, García-Pagán JC .
    Reference: Liver International 2019.
  • Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer

    Authors: Herreros-Villanueva M, Duran-Sanchon S, Martín AC, Pérez-Palacios R, Vila-Navarro E, Marcuello M, Diaz-Centeno M, Cubiella J, Diez MS, Bujanda L, Lanas A, Jover R, Hernández V, Quintero E, José Lozano J, García-Cougil M, Martínez-Arranz I, Castells A, Gironella M, Arroyo R .
    Reference: Clinical And Translational Gastroenterology 2019.
  • Porto-sinusoidal vascular disease: proposal and description of a novel entity

    Authors: De Gottardi A, Rautou PE, Schouten J, Rubbia-Brandt L, Leebeek F, Trebicka J, Murad SD, Vilgrain V, Hernandez-Gea V, Nery F, Plessier A, Berzigotti A, Bioulac-Sage P, Primignani M, Semela D, Elkrief L, Bedossa P, Valla D, Garcia-Pagan JC, VALDIG group.
    Reference: Lancet Gastroenterology & Hepatology 2019.
  • Idiopathic Portal Hypertension

    Authors: Hernandez Gea, Virginia; Baiges, Anna; Turon, Fanny; García-Pagán JC.
    Reference: Hepathology 2018.
  • Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury.

    Authors: Maria Ruart; Laia Chavarria; Genís Campreciós; Nuria Suárez Herrera; Carla Montironi; Sergi Guixé Muntet; Jaume Bosch; Scott L Friedman; Juan Carlos Garcia Pagán; Virginia Hernández Gea.
    Reference: Journal Of Hepatology 2018.
  • Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.

    Authors: Simón-Talero M; Roccarina D; Martinez J; Lampichler K; Baiges A; Low G; Llop E; Praktiknjo M; Maurer MH; Zipprich A; Triolo M; Vangrinsven G; Garcia-Martinez R; Dam A; Majumdar A; Picon C; Toth D; Darnell A; Abraldes JG; Lopez M; Kukuk G; Krag A; Bañares R; Laleman W; La Mura V; Ripoll C; Berzigotti A; Trebicka J; Calleja JL; Tandon P; Hernandez Gea, Virginia; Reiberger T; Albillos A; sochatzis EA; Augustin S; Genescà J.
    Reference: 2018.

Featured Projects

  • La autofagia endotelial gobierna la respuesta de la célula hepática estrellada al daño hepático: regeneración o fibrosis? Análisis del secretoma endotelial para el desarrollo de nuevos tratamientos antibibroticos

    Principal investigator: Virginia Hernandez Gea
    Funder: Instituto de Salud Carlos III
    Code: PI17/00398
    Duration: 01/01/2018 - 31/12/2020
  • Papel de la autofagia en la modulación de la disfunción endotelial y la fibrosis: caracterización de una nueva diana terapéutica para el desarrollo de nuevos tratamientos antifibróticos

    Principal investigator: Virginia Hernández Gea
    Funder: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Instituto de Salud Carlos III
    Code: FIS PI14/00182
    Duration: 01/01/2014 - 31/12/2017
  • HEPTROMIC: Genomic predictors and oncogenic drivers in hepatocellular carcinoma

    Principal investigator: Jessica Zucman Rossi
    Duration: 03/09/2012 - 31/05/2013
  • Autophagy During hepatic stellate cell activation in alcoholic liver injury

    Principal investigator: Scott L. Friedman
    Duration: 01/01/2011 - 30/09/2012
  • Role of Stellate Cells in Hepatic Fibrosis

    Principal investigator: Scott L. Friedman
    Duration: 01/01/2011 - 30/09/2012